DEF 14A: Certara, Inc. Sets Date for 2024 Annual Stockholders Meeting, Proposes Officer Liability Limit

Certara, Inc. will hold its annual stockholders meeting virtually on May 21, 2024, to vote on director elections, amendments to the Certificate of Incorporation, ratification of the accounting firm, and executive compensation.

Summary

• Certara, Inc. will hold its 2024 Annual Meeting of Stockholders on May 21, 2024, at 9:00 a.m. Eastern Time, as a virtual meeting.
• Stockholders of record as of March 28, 2024, are eligible to vote.
• The proposals include the election of Class I directors, amendments to the Certificate of Incorporation to limit officer liability and make technical changes, ratification of the appointment of RSM US LLP as the independent registered public accounting firm, and an advisory vote on executive compensation.
• The Board of Directors recommends voting 'FOR' all proposals.
• The proxy statement and accompanying proxy card were first made available on or about April 10, 2024.
• The meeting will address the election of three Class I directors for a three-year term expiring at the 2027 annual meeting.
• Amendments to the Certificate of Incorporation include limiting the liability of certain officers and removing outdated language.
• The advisory vote on executive compensation concerns the compensation of named executive officers.

Sentiment

Score: 7

Explanation: The document is a standard proxy statement, presenting information in a neutral and informative tone. The proposals are generally routine, and the board's recommendations are clear.

Positives

• The proposal to limit officer liability aims to attract and retain top talent by providing similar protections afforded to directors.
• The virtual meeting format enables full and equal participation by all stockholders with internet access.
• The company has taken actions to be responsive to stockholder feedback, including expanding stockholder outreach efforts and enhancing proxy disclosure.

Future Outlook

The company is focused on optimizing biosimulation in drug development, preclinical and clinical research, regulatory submissions, and market access.

Management Comments

• William F. Feehery, Chief Executive Officer, cordially invites stockholders to attend the annual meeting and emphasizes the importance of their vote.

Industry Context

Certara is a global leader in biosimulation, providing software and technology-driven services to optimize drug development processes.

Corporate Governance

Related Party Transactions

• The company is party to a registration rights agreement with Arsenal, dated November 3, 2022.
• Pursuant to the Stockholders Agreement with Arsenal, Arsenal has the right to nominate two directors to our Board under certain conditions.
• We have entered into an indemnification agreement with each of our directors and executive officers.

Stakeholder Impact

• Shareholders have the opportunity to vote on key corporate governance matters.
• Employees may be affected by the proposal to limit officer liability, potentially improving the company's ability to attract and retain executive talent.

Next Steps

• Stockholders are encouraged to vote on the proposals before the deadlines.
• The company will announce preliminary voting results at the Annual Meeting and file final results with the SEC.

Key Dates

Keywords

annual meeting, proxy statement, directors, officer liability, executive compensation, RSM US LLP, Certara, stockholders, corporate governance, voting